{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:51:41Z","timestamp":1789642301196,"version":"4.0.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.lfs.2022.121145","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T12:14:59Z","timestamp":1667477699000},"page":"121145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"PA","title":["The hepatoprotective effects of n3-polyunsaturated fatty acids against non-alcoholic fatty liver disease in diabetic rats through the FOXO1\/PPAR\u03b1\/GABARAPL1 signalling pathway"],"prefix":"10.1016","volume":"311","author":[{"given":"Nehal M.","family":"Ramadan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Elmasry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan Reda Hassan","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"El-Mesery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma M.","family":"Eraky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2022.121145_bb0005","doi-asserted-by":"crossref","DOI":"10.1177\/20420188211055557","article-title":"NAFLD in type 1 diabetes: overrated or underappreciated?","volume":"12","author":"Mertens","year":"2021","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2022.121145_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109827","article-title":"Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetes","volume":"186","author":"de Vries","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.lfs.2022.121145_bb0015","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1210\/clinem\/dgaa575","article-title":"Prevalence of nonalcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"105","author":"de Vries","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2022.121145_bb0020","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.metabol.2015.09.002","article-title":"Insulin resistance in type 1 diabetes mellitus","volume":"64","author":"Kaul","year":"2015","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.lfs.2022.121145_bb0025","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jcmgh.2018.10.016","article-title":"Resolving the paradox of hepatic insulin resistance","volume":"7","author":"Santoleri","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2022.121145_bb0030","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dbi16-0010","article-title":"Unraveling the paradox of selective insulin resistance in the liver: the brain-liver connection","volume":"65","author":"Ferris","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2022.121145_bb0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: a pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.lfs.2022.121145_bb0040","first-page":"9","article-title":"A review of FoxO1-regulated metabolic diseases and related drug discoveries","author":"Peng","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2022.121145_bb0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cmet.2008.06.006","article-title":"Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation","volume":"8","author":"Dong","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.lfs.2022.121145_bb0050","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1210\/en.2006-0541","article-title":"Aberrant forkhead box O1 function is associated with impaired hepatic metabolism","volume":"147","author":"Qu","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2022.121145_bb0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biocel.2015.12.011","article-title":"Calcitonin gene-related peptide inhibits autophagic-lysosomal proteolysis through cAMP\/PKA signaling in rat skeletal muscles","volume":"72","author":"Machado","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.lfs.2022.121145_bb0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.clnu.2010.06.001","article-title":"The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease","volume":"30","author":"Shapiro","year":"2011","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.lfs.2022.121145_bb0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1017\/S0029665117003950","article-title":"Very long-chain n-3 fatty acids and human health: fact, fiction and the future","volume":"77","author":"Calder","year":"2018","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.lfs.2022.121145_bb0070","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev-nutr-071812-161230","article-title":"Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease","volume":"33","author":"Scorletti","year":"2013","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.lfs.2022.121145_bb0075","first-page":"138","article-title":"Prevention of insulin resistance by n-3 polyunsaturated fatty acids","volume":"12","author":"Fedor","year":"2009","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.lfs.2022.121145_bb0080","doi-asserted-by":"crossref","first-page":"E1391","DOI":"10.1152\/ajpendo.00584.2012","article-title":"Influence of fish oil on skeletal muscle mitochondrial energetics and lipid metabolites during high-fat diet","volume":"304","author":"Lanza","year":"2013","journal-title":"Am. J. Phys. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2022.121145_bb0085","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.nutres.2013.07.004","article-title":"A high ratio of dietary n-3\/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats","volume":"33","author":"Liu","year":"2013","journal-title":"Nutr. Res."},{"key":"10.1016\/j.lfs.2022.121145_bb0090","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2337\/db06-1206","article-title":"N-3 fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator-activated receptor-alpha-dependent manner","volume":"56","author":"Neschen","year":"2007","journal-title":"Diabetes"},{"issue":"30","key":"10.1016\/j.lfs.2022.121145_bb0095","first-page":"1535","article-title":"Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women","volume":"2006","author":"Krebs","year":"2005","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.lfs.2022.121145_bb0100","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2337\/db12-1042","article-title":"Omega-3 fatty acids reduce adipose tissue macrophages in human subjects with insulin resistance","volume":"62","author":"Spencer","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2022.121145_bb0105","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1096\/fj.08-125674","article-title":"Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins","volume":"23","author":"Gonz\u00e1lez-P\u00e9riz","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2022.121145_bb0110","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1055\/a-1162-8196","article-title":"Liraglutide effect on ventricular transient outward K + channel and Connexin-43 protein expression","volume":"129","author":"Ramadan","year":"2021","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.lfs.2022.121145_bb0115","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/231825","article-title":"Metformin ameliorates podocyte damage by restoring renal tissue podocalyxin expression in type 2 diabetic rats","volume":"2015","author":"Zhai","year":"2015","journal-title":"J.Diabetes Res."},{"key":"10.1016\/j.lfs.2022.121145_bb0120","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1038\/s41598-021-85337-9","article-title":"Supplementation of polyunsaturated fatty acids (PUFAs) and aerobic exercise improve functioning, morphology, and redox balance in prostate obese rats","volume":"11","author":"Veras","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2022.121145_bb0125","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1210\/jcem.85.7.6661","article-title":"Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans","volume":"85","author":"Katz","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2022.121145_bb0130","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1369\/00221554211041607","article-title":"Independent of calorie intake, short-term alternate-day fasting alleviates NASH, with modulation of markers of lipogenesis, autophagy, apoptosis, and inflammation in rats","volume":"69","author":"Elsayed","year":"2021","journal-title":"J.Histochem.Cytochem."},{"key":"10.1016\/j.lfs.2022.121145_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e08171","article-title":"Modulation of COX-2 and NADPH oxidase-4 by alpha-lipoic acid ameliorates busulfan-induced pulmonary injury in rats","volume":"7","author":"Elhadidy","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.lfs.2022.121145_bb0140","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.lfs.2022.121145_bb0145","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.lfs.2022.121145_bb0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2022.121145_bb0155","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s13300-017-0333-9","article-title":"A review of insulin resistance in type 1 diabetes: is there a place for adjunctive metformin?","volume":"9","author":"Priya","year":"2018","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.lfs.2022.121145_bb0160","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pharmthera.2017.07.007","article-title":"Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease","volume":"181","author":"Jump","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2022.121145_bb0165","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00125-009-1305-z","article-title":"N-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet","volume":"52","author":"Kuda","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.lfs.2022.121145_bb0170","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00535-003-1300-y","article-title":"Effects of antihyperlipidemic agents on hepatic insulin sensitivity in perfused Goto-Kakizaki rat liver","volume":"39","author":"Matsuura","year":"2004","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.lfs.2022.121145_bb0175","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1677\/jme.0.0320519","article-title":"Dietary protein deprivation decreases the serine phosphorylation of insulin receptor substrate-1 in rat skeletal muscle","volume":"32","author":"Toyoshima","year":"2004","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.lfs.2022.121145_bb0180","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hep.24011","article-title":"C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: role of mitogen-activated protein kinases","volume":"53","author":"Xi","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2022.121145_bb0185","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/diacare.24.3.588","article-title":"Recent advances in our understanding of insulin action and insulin resistance","volume":"24","author":"Le Roith","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2022.121145_bb0190","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jnim.2018.02.002","article-title":"The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: a narrative review","volume":"14","author":"Itsiopoulos","year":"2018","journal-title":"J.Nutr.Intermediary Metab."},{"key":"10.1016\/j.lfs.2022.121145_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104984","article-title":"Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies","volume":"159","author":"Zhang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2022.121145_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115157","article-title":"Ceramide de novo synthesis in non-alcoholic fatty liver disease: pathogenic mechanisms and therapeutic perspectives","volume":"202","author":"Yu","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2022.121145_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022775","article-title":"Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model","volume":"6","author":"Gorden","year":"2011","journal-title":"PloS one"},{"key":"10.1016\/j.lfs.2022.121145_bb0210","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","article-title":"Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2","volume":"55","author":"Copps","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.lfs.2022.121145_bb0215","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.1038\/ncomms8079","article-title":"FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization","volume":"6","author":"Os","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2022.121145_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016556","article-title":"Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis","volume":"6","author":"Xia","year":"2011","journal-title":"PloS one"},{"key":"10.1016\/j.lfs.2022.121145_bb0225","doi-asserted-by":"crossref","first-page":"E718","DOI":"10.1152\/ajpendo.00156.2003","article-title":"Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice","volume":"285","author":"Altomonte","year":"2003","journal-title":"Am. J. Phys. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2022.121145_bb0230","doi-asserted-by":"crossref","first-page":"E421","DOI":"10.1152\/ajpendo.00157.2006","article-title":"PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1","volume":"292","author":"Qu","year":"2007","journal-title":"Am. J. Phys. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2022.121145_bb0235","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.2337\/db11-0248","article-title":"Suppression of FoxO1 activity by long-chain fatty acyl analogs","volume":"60","author":"Zatara","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2022.121145_bb0240","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41467-022-28692-z","article-title":"Kindlin-2 haploinsufficiency protects against fatty liver by targeting Foxo1 in mice","volume":"13","author":"Gao","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2022.121145_bb0245","first-page":"2464","article-title":"Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism","volume":"116","author":"Matsumoto","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2022.121145_bb0250","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/hep.24295","article-title":"Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway","volume":"53","author":"Li","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2022.121145_bb0255","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cmet.2007.08.006","article-title":"Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver","volume":"6","author":"Matsumoto","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.lfs.2022.121145_bb0260","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fphys.2020.00177","article-title":"Protective properties of FOXO1 inhibition in a murine model of non-alcoholic fatty liver disease are associated with attenuation of ER stress and necroptosis","volume":"11","author":"Ding","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2022.121145_bb0265","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.apsb.2021.07.021","article-title":"Therapeutic regulation of autophagy in hepatic metabolism","volume":"12","author":"Byrnes","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.lfs.2022.121145_bb0270","first-page":"E856","article-title":"Effects of streptozotocin-induced diabetes on rough endoplasmic reticulum and lysosomes of rat liver","volume":"263","author":"Lenk","year":"1992","journal-title":"Am.J.Physiol."},{"key":"10.1016\/j.lfs.2022.121145_bb0275","doi-asserted-by":"crossref","first-page":"31484","DOI":"10.1074\/jbc.M109.033936","article-title":"Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin","volume":"284","author":"Liu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2022.121145_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051632","article-title":"Autophagy plays an essential role in mediating regression of hypertrophy during unloading of the heart","volume":"8","author":"Hariharan","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.lfs.2022.121145_bb0285","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1096\/fj.201600698R","article-title":"LC3\/GABARAP family proteins: autophagy-(un)related functions","volume":"30","author":"Schaaf","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2022.121145_bb0290","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1038\/emboj.2010.74","article-title":"LC3 and GATE-16\/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis","volume":"29","author":"Weidberg","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.lfs.2022.121145_bb0295","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cmet.2010.04.005","article-title":"Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance","volume":"11","author":"Yang","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.lfs.2022.121145_bb0300","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nm.3014","article-title":"Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine","volume":"19","author":"Kim","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2022.121145_bb0305","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1210\/me.2013-1153","article-title":"Autophagy deficiency by hepatic FIP200 deletion uncouples steatosis from liver injury in NAFLD","volume":"27","author":"Ma","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.lfs.2022.121145_bb0310","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jcmgh.2020.10.006","article-title":"S100A11 promotes liver steatosis via FOXO1-mediated autophagy and lipogenesis","volume":"11","author":"Zhang","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2022.121145_bb0315","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s00125-011-2238-x","article-title":"Restoration of hepatic glycogen deposition reduces hyperglycaemia, hyperphagia and gluconeogenic enzymes in a streptozotocin-induced model of diabetes in rats","volume":"54","author":"Ros","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.lfs.2022.121145_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102093","article-title":"Glycogen-autophagy: molecular machinery and cellular mechanisms of glycophagy","volume":"298","author":"Koutsifeli","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2022.121145_bb0325","doi-asserted-by":"crossref","first-page":"28319","DOI":"10.1074\/jbc.M109.024406","article-title":"FoxO transcription factors promote autophagy in cardiomyocytes*","volume":"284","author":"Sengupta","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2022.121145_bb0330","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2337\/db14-0728","article-title":"Liver glycogen reduces food intake and attenuates obesity in a high-fat diet-fed mouse model","volume":"64","author":"L\u00f3pez-Soldado","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2022.121145_bb0335","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jnutbio.2011.11.003","article-title":"Docosahexaenoic acid suppresses the expression of FoxO and its target genes","volume":"23","author":"Chen","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.lfs.2022.121145_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173676","article-title":"Chronic activation of PPAR\u03b1 with fenofibrate reduces autophagic proteins in the liver of mice independent of FGF21","volume":"12","author":"Jo","year":"2017","journal-title":"PloS one"},{"key":"10.1016\/j.lfs.2022.121145_bb0345","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/hep.27297","article-title":"The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice","volume":"60","author":"Pawlak","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2022.121145_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032249","article-title":"FoxO1 gain of function in the pancreas causes glucose intolerance, polycystic pancreas, and islet hypervascularization","volume":"7","author":"Kikuchi","year":"2012","journal-title":"PloS one"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522008451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522008451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:03:15Z","timestamp":1758402195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522008451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":70,"alternative-id":["S0024320522008451"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121145","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The hepatoprotective effects of n3-polyunsaturated fatty acids against non-alcoholic fatty liver disease in diabetic rats through the FOXO1\/PPAR\u03b1\/GABARAPL1 signalling pathway","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121145"}}